0I3I.LSE Cooper Cos.

Healthcare Commercial Services & Supplies London Exchange
- USD
Market cap
-
P/E
3.2x
P/B
-
ROE
7.8%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Jul 2026.

Is 0I3I.LSE undervalued?

Graham number

The Graham number of Cooper Cos. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Cooper Cos. fundamental analysis

No fundamental analysis for Cooper Cos. yet.

Cooper Cos. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Cooper Cos.

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifocal contact lenses that address vision challenges, such as astigmatism, presbyopia, and myopia. Its CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices…

Full company profile